The total number of records retrieved from this search are 2. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5371	Virus nameMaraba virus	Virus strainMG1	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineMurine triple negative breast cancer cell line	Cell lineE0771	Concentration of cell lineNA	In-vitro toxicityNA	AssayCoomassie brilinat blue staining	In-vitro virus concentration4 micromolar	In-vitro result90% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialIn clinical trial for various cancer cell line	PMID27503504
IDOV_5374	Virus nameMaraba virus	Virus strainMG1	Virus genome typeRNA	Virus familyRhabdoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with 2 micromolar palcitaxel for 48 hours	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineMurine triple negative breast cancer cell line	Cell lineE0771	Concentration of cell lineNA	In-vitro toxicityNA	AssayCoomassie brilinat blue staining	In-vitro virus concentration4 micromolar	In-vitro result20% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectLevel of IFN beta production does not effected by combination	Clinical trialIn clinical trial for various cancer cell line	PMID27503504